Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 54 (1 Suppl), S85-96

Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension

Affiliations
Review

Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension

Marius M Hoeper et al. J Am Coll Cardiol.

Abstract

The 4th World Symposium on Pulmonary Hypertension was the first international meeting to focus not only on pulmonary arterial hypertension (PAH) but also on the so-called non-PAH forms of pulmonary hypertension (PH). The term "non-PAH PH" summarizes those forms of PH that are found in groups 2 to 5 of the current classification of PH, that is, those forms associated with left heart disease, chronic lung disease, recurrent venous thromboembolism, and other diseases. Many of these forms of PH are much more common than PAH, but all of them have been less well studied, especially in terms of medical therapy. The working group on non-PAH PH focused mainly on 4 conditions: chronic obstructive lung disease, interstitial lung disease, chronic thromboembolic PH, and left heart disease. The medical literature regarding the role of PH in these diseases was reviewed, and recommendations regarding diagnosis and treatment of PH in these conditions are provided. Given the lack of robust clinical trials addressing PH in any of these conditions, it is important to conduct further studies to establish the role of medical therapy in non-PAH PH.

Similar articles

  • Pulmonary arterial hypertension.
    Montani D, Günther S, Dorfmüller P, Perros F, Girerd B, Garcia G, Jaïs X, Savale L, Artaud-Macari E, Price LC, Humbert M, Simonneau G, Sitbon O. Montani D, et al. Orphanet J Rare Dis. 2013 Jul 6;8:97. doi: 10.1186/1750-1172-8-97. Orphanet J Rare Dis. 2013. PMID: 23829793 Free PMC article. Review.
  • Properly diagnosing pulmonary arterial hypertension.
    Preston IR. Preston IR. Am J Cardiol. 2013 Apr 16;111(8 Suppl):2C-9C. doi: 10.1016/j.amjcard.2013.01.318. Am J Cardiol. 2013. PMID: 23558028
  • Pulmonary hypertension in chronic lung diseases.
    Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL. Seeger W, et al. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. J Am Coll Cardiol. 2013. PMID: 24355635 Review.
  • [Investigation of pulmonary hypertension].
    Natali D, Simonneau G, Humbert M, Montani D. Natali D, et al. Rev Pneumol Clin. 2008 Jun;64(3):151-61. doi: 10.1016/j.pneumo.2008.05.001. Epub 2008 Jul 7. Rev Pneumol Clin. 2008. PMID: 18656791 Review. French.
  • ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre.
    Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ, Billings C, Lawrie A, Sabroe I, Akil M, O'Toole L, Kiely DG. Hurdman J, et al. Eur Respir J. 2012 Apr;39(4):945-55. doi: 10.1183/09031936.00078411. Epub 2011 Sep 1. Eur Respir J. 2012. PMID: 21885399
See all similar articles

Cited by 75 articles

See all "Cited by" articles

MeSH terms

Feedback